ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 694698 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 694698; 2) Community: the network communities that were significantly associated with the response to NSC 694698; 3) Molecule: the relationships between components within communities and NSC 694698; 4) MDR: the compounds that were significantly associated with the NSC 694698.

NSC Compound Enrichment Correlation
NSC 642915 Null 0.00578566967432518 0.3386766
NSC 681634 Camptothecin Derivative 0.00578566967432518 0.077260099
NSC 709502 Null 0.00578566967432525 -0.18520497
NSC 711074 Null 0.00578566967432525 0.42008474
NSC 723001 Diethyl-N[4-(3-thienylquinoxalyn-2-yl)oxiphenylacetyl]-L-glu tamate 0.00578566967432525 -0.34881171
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.00578566967432525 0.51975967
NSC 763587 Null 0.00578566967432525 0.38601666
NSC 174121 Methotrexate Derivative 0.00578566967432527 0.3134853
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.00578566967432527 0.49203533
NSC 631197 9-N-(N'-chloroethyl-N'-ethyl-1,4-diamino-butyl)2-methoxy acridine dihydrochloride 0.00578566967432527 0.32240549
Total:85  Current:17    [First] [Prev] [Next] [Last]